Evidence map›Paper›PMID 31337984›Full record

ArticleInternational journal of biological sciences2019

miR-155-5p Promotes Dorsal Root Ganglion Neuron Axonal Growth in an Inhibitory Microenvironment via the cAMP/PKA Pathway.

Tianyi Wang, Bo Li, Zhijie Wang, Xin Yuan, Chuanjie Chen, Yanjun Zhang, Ziwei Xia, Xin Wang, Mei Yu, Wen Tao and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Tianyi WangDepartment of Orthopedics, The 981st Hospital of the Chinese People's Liberation Army, Chengde 067000, Hebei Province, P.R. China.
Bo LiDepartment of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Zhijie WangDepartment of Pediatric Internal Medicine, Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, P.R. China.
Xin YuanDepartment of Spine Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, P.R. China.
Chuanjie ChenDepartment of Orthopedics, Chengde Central Hospital, Chengde 067000, Hebei Province, P.R. China.
Yanjun ZhangDepartment of Spine Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, P.R. China.
Ziwei XiaDepartment of Orthopedics, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Xin WangChengde Medical University, Chengde 067000, Hebei Province, P.R. China.
Mei YuLeukemia Center, Chinese Academy of Medical Sciences & Peking Union of Medical College, Institute of Hematology & Hospital of Blood Diseases, Tianjin 30020, P.R. China.
Wen TaoChengde Medical University, Chengde 067000, Hebei Province, P.R. China.
Liang ZhangDepartment of Orthopedics, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Xu WangDepartment of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Zheng ZhangDepartment of Orthopedics, The 981st Hospital of the Chinese People's Liberation Army, Chengde 067000, Hebei Province, P.R. China.
Xiaoling GuoDepartment of Neurology, The 981st Hospital of the Chinese People's Liberation Army, Chengde 067000, Hebei Province, P.R. China.
Guangzhi NingDepartment of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Shiqing FengDepartment of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Xueming ChenDepartment of Spine Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 100000, P.R. China.
Tianjin Medical University General Hospital · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNChinese People's Liberation Army · CNChengde Medical University · CNTianjin Medical University · CNInstitute of Hematology & Blood Diseases Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensory dysfunction post spinal cord injury causes patients great distress. Sciatic nerve conditioning injury (SNCI) has been shown to restore sensory function after spinal cord dorsal column injury (SDCL); however, the underlying mechanism of this recovery remains unclear. We performed a microarray assay to determine the associated miRNAs that might regulate the process of SNCI promoting SDCL repair. In total, 13 miRNAs were identified according to our inclusion criteria, and RT-qPCR was used to verify the microarray results. Among the 13 miRNAs, the miR-155-5p levels were decreased at 9 h, 3 d, 7 d, 14 d, 28 d, 2 m and 3 m timepoints in the SDCL group, while the SNCI group had a smaller decrease. Thus, miR-155-5p was chosen for further study after a literature review and an analysis with the TargetScan online tool. Specifically, miR-155-5p targets PKI-α, and the expression pattern of PKI-α was opposite that of miR-155-5p in both the SDCL and SNCI groups. Interestingly, miR-155-5p could promote dorsal root ganglion (DRG) neuron axon growth via the cAMP/PKA pathway and in a TNF-α, IL-1β or MAG inhibitory microenvironment in vitro. Furthermore, miR-155-5p could regulate the cAMP/PKA pathway and promote sensory conduction function recovery post dorsal column injury as detected by NF-200 immunohistochemistry, somatosensory-evoked potentials, BBB scale and tape removal test. Collectively, our results demonstrated that miR-155-5p participates in the molecular mechanism by which SNCI promotes the repair of SDCL and that upregulated miR-155-5p can repair SDCL by enhancing DRG neuron axon growth via the cAMP/PKA pathway. These findings suggest a novel treatment target for spinal cord injury.

Indexed as

AnimalsAxonsBehavior, AnimalCyclic AMPCyclic AMP-Dependent Protein KinasesFemaleGanglia, SpinalHEK293 CellsHumansImmunohistochemistryLocomotionMicroRNAsNeuronsOligonucleotide Array Sequence AnalysisRatsRats, WistarCyclic AMPCyclic AMP-Dependent Protein KinasesMicroRNAsMIRN155 microRNA, ratcAMP/PKAmicroRNAmiR-155-5psensory functionspinal cord dorsal column injury

Identifiers

PMID31337984
PMCPMC6643145
OpenAlexW2952849113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.